New products
MicroPort launches LBBOT Solution commercially in Europe and Australia
MicroPort CardioFlow has launched its LBBOT Solution commercially in Europe and Australia following regulatory approvals. The solution addresses left bundle branch block treatment, expanding the vendor's cardiac care portfolio in international markets.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network